Zoledronic acid 5mg100ml solution for infusion vials Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

zoledronic acid 5mg100ml solution for infusion vials

sun pharmaceutical industries europe b.v. - zoledronic acid monohydrate - solution for infusion - 50microgram/1ml

Ceziboe 0.25 mg solution for injection in pre-filled syringe Irlanti - englanti - HPRA (Health Products Regulatory Authority)

ceziboe 0.25 mg solution for injection in pre-filled syringe

sun pharmaceutical industries europe b.v. - cetrorelix - solution for injection in pre-filled syringe - 0.25 milligram(s) - cetrorelix

Amoxicillin SUN 750 mg dispersible tablets Malta - englanti - Medicines Authority

amoxicillin sun 750 mg dispersible tablets

sun pharmaceutical industries europe b.v. polarisavenue 87, 2132, jh hoofdorp, netherlands - amoxicillin trihydrate - dispersible tablet - amoxicillin trihydrate 750 mg - antibacterials for systemic use

Warfarin Teva 0.5mg Tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

warfarin teva 0.5mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 0.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extensiona and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.

Warfarin Teva 1 mg Tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

warfarin teva 1 mg tablets

sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 1 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.